Company Encyclopedia
View More
name
CHINA ORAL IND
08406.HK
China Oral Industry Group Holdings Limited, an investment holding company, manufactures and sells inflatable products and related accessories in the People’s Republic of China, Europe, Australia, Oceania, North America, rest of Asia, Central and South America, and Africa. It operates through three segments, Inflatable Products Business, Dental Clinic Business, and Yarn and Polyester Business. The company offers inflatable playgrounds with air blowers; other inflatable products; and related accessories, as well as PVC coating, PVC laminated oxford, and plastic products. It is also involved in the subcontracting works.
48.90 B
08406.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Leisure ProductsIndustry
Industry Ranking10/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-9.97%D
    • Profit Margin-6.15%D
    • Gross Margin17.50%D
  • Growth ScoreC
    • Revenue YoY9.76%B
    • Net Profit YoY6.30%C
    • Total Assets YoY-16.28%E
    • Net Assets YoY12.75%B
  • Cash ScoreD
    • Cash Flow Margin-1626.88%E
    • OCF YoY9.76%B
  • Operating ScoreA
    • Turnover1A
  • Debt ScoreB
    • Gearing Ratio28.08%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CHINA ORAL IND: Zhan Lijuan resigns as co-company secretary and authorized representative

    According to the Zhitong Finance APP, CHINA ORAL IND announced that Ms. Zhan Lijuan will resign as the co-company secretary and authorized representative of the company due to other business commitments, effective September 23, 2025. Ms. Chen Leyan will continue to serve as the company secretary and has been appointed as the authorized representative

    Zhitong·
    HK
    08406
    -1.18%
    Zhitong·
    HK
    08406
    -1.18%

    CHINA ORAL IND announced its interim results, with a net profit of 4.069 million yuan, a year-on-year increase of 3.62 times

    According to the Zhitong Finance APP, CHINA ORAL IND announced its mid-year results for 2025, with revenue of approximately 109 million yuan, a year-on-year decrease of 12.35%; net profit of 4.069 million yuan, a year-on-year increase of 3.62 times; earnings per share of 0.3 cents

    Zhitong·
    HK
    08406
    -1.18%
    Zhitong·
    HK
    08406
    -1.18%

    CHINA ORAL IND: Geng Chuanlong appointed as independent non-executive director

    According to the announcement from CHINA ORAL IND, Mr. Geng Chuanlong has been appointed as the independent non-executive director of the company, effective from August 29, 2025. Mr. Geng has also been appointed as a member of the Audit Committee, Nomination Committee, and Remuneration Committee, effective from August 29, 2025

    Zhitong·
    HK
    08406
    -1.18%
    Zhitong·
    HK
    08406
    -1.18%

    CHINA ORAL IND suggests increasing the statutory capital

    According to the announcement from CHINA ORAL IND, in order to enable the company to raise funds more flexibly in the future, it proposes to seek shareholder approval through an ordinary resolution to increase the authorized share capital from HKD 20 million (divided into 2 billion shares with a par value of HKD 0.01 per share) to HKD 50 million (divided into 5 billion shares with a par value of HKD 0.01 per share) by adding an additional 3 billion new unissued shares

    Zhitong·
    HK
    08406
    -1.18%
    Zhitong·
    HK
    08406
    -1.18%

    CHINA ORAL IND: Actively promoting the deep application of artificial intelligence computing resources in core medical and oral businesses, and developing related digital infrastructure

    CHINA ORAL IND announced that it will actively promote the application of artificial intelligence (AI) computing resources in core medical and oral businesses, and develop related digital infrastructure. The group aims to establish a medical AI computing power network to enhance the intelligent analysis capabilities of medical imaging, pathological diagnosis, and genetic analysis, supporting clinical decision-making. By introducing internationally advanced technologies, the group hopes to improve service quality and operational efficiency, expand the scope of services, attract more partners, promote sustainable development, and create long-term value for shareholders

    Zhitong·
    HK
    08406
    -1.18%
    Zhitong·
    HK
    08406
    -1.18%
    © 2025 Longbridge｜Disclaimer